News

BoomerangFX Announces AI Search Marketing Offering

BoomerangFX AI Search Marketing offering begins rolling out in November 2026 in the USA, Canada and UK.

by Body & Soul Newsroom  · 

Person standing beside a screen showing wellness clinic search advertising.
Person standing beside a screen showing wellness clinic search advertising. Photo: BoomerangFX

BoomerangFX, a global AI-powered clinic software and marketing automation company purpose-built for private-pay healthcare, today announced the launch of its next-generation AI Search Marketing offering. Beginning November 2026, the rollout will start in the USA, Canada and UK. The offering brings AI Search Advertising on OpenAI’s ChatGPT and Search Optimization Intelligence for Claude and Gemini into the company’s GROW SaaS product suite. It is enhanced by AUVIA™, the AI Clinic Co-Pilot, and connects patient inquiries to conversion and end-to-end clinic practice management.

AI Search Advertising Rollout

BoomerangFX describes the offering as a platform connecting ChatGPT ad campaigns, optimization for Claude and Gemini, and agentic patient engagement with integrated electronic medical records, scheduling and payments. The offering is available through a GROW Platinum upgrade for existing and new clients.

According to an August 2026 Pew Research Center report cited by the company, 34% of U.S. adults now use AI chatbots for at least one health or medical reason.

Jerome Dwight, Co-Founder & CEO at BoomerangFX, said:

“The next era of clinic growth will be shaped by how effectively practices turn AI discovery into lasting patient relationships. We are bringing advertising, search visibility, patient conversations and clinical operations into one platform, helping clinics connect the demand they create with the experience they deliver.”

Website And Practice Tools

The GROW product suite’s Smart Website Intelligence organizes treatment expertise, clinician credentials, practice locations and patient education into website content. Search Optimization Intelligence applies BoomerangFX’s proprietary data science to help AI platforms discover, interpret and reference that information when prospective patients research care.

Its AUVIA™ agentic workflows support immediate lead response and personalized follow-up, while RUN, GROW and ELEVATE bring together practice management, lead capture and specialty marketing services.

Planned Market Expansion

BoomerangFX plans to expand the offering across Ireland, Germany, Australia, India and Latin America. ChatGPT ad activation depends on market availability, practice specialty and advertiser approval. Search Optimization Intelligence supports organic discoverability on Claude and Gemini, while inclusion, rankings and recommendations remain determined by each platform. Paid placements are separate from AI-generated answers.

Dr. Stephen Mulholland, Co-Founder and Chief Clinical Architect at BoomerangFX, said:

“Aesthetic and wellness practices need technology that understands the language of their specialties and the expectations of their patients. Connecting specialty-level marketing with responsive communication and a complete clinical record helps practices deliver a more consistent experience from the first question through continuing care.”

Earlier coverage

Similar Content